BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 35051532)

  • 1. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer.
    Kang J; La Manna F; Bonollo F; Sampson N; Alberts IL; Mingels C; Afshar-Oromieh A; Thalmann GN; Karkampouna S
    Cancer Lett; 2022 Apr; 530():156-169. PubMed ID: 35051532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of exosomes in prostate cancer bone metastasis.
    Lv T; Li Z; Wang D; Guo X; Zhang X; Cao J; Wang Z
    Arch Biochem Biophys; 2023 Oct; 748():109784. PubMed ID: 37816420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells.
    McGovern JA; Bock N; Shafiee A; Martine LC; Wagner F; Baldwin JG; Landgraf M; Lahr CA; Meinert C; Williams ED; Pollock PM; Denham J; Russell PJ; Risbridger GP; Clements JA; Loessner D; Holzapfel BM; Hutmacher DW
    Commun Biol; 2021 Aug; 4(1):1014. PubMed ID: 34462519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular matrix in tumor progression and metastasis.
    Eble JA; Niland S
    Clin Exp Metastasis; 2019 Jun; 36(3):171-198. PubMed ID: 30972526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastasis and the metastatic niche.
    Ren G; Esposito M; Kang Y
    J Mol Med (Berl); 2015 Nov; 93(11):1203-12. PubMed ID: 26275789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis.
    Li S; Kang Y; Zeng Y
    Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189033. PubMed ID: 38040267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Exosomes in Prostate Cancer Metastasis.
    Akoto T; Saini S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The origin of prostate metastases: emerging insights.
    Santoni M; Piva F; Scarpelli M; Cheng L; Lopez-Beltran A; Massari F; Iacovelli R; Berardi R; Santini D; Montironi R
    Cancer Metastasis Rev; 2015 Dec; 34(4):765-73. PubMed ID: 26363603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche.
    Godebu E; Muldong M; Strasner A; Wu CN; Park SC; Woo JR; Ma W; Liss MA; Hirata T; Raheem O; Cacalano NA; Kulidjian AA; Jamieson CA
    J Transl Med; 2014 Oct; 12():275. PubMed ID: 25278011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating the immune microenvironment of prostate cancer induced bone disease.
    Ihle CL; Owens P
    Mol Carcinog; 2020 Jul; 59(7):822-829. PubMed ID: 32233011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling.
    Almeida SFF; Santos L; Sampaio-Ribeiro G; Ferreira HRS; Lima N; Caetano R; Abreu M; Zuzarte M; Ribeiro AS; Paiva A; Martins-Marques T; Teixeira P; Almeida R; Casanova JM; Girão H; Abrunhosa AJ; Gomes CM
    J Exp Clin Cancer Res; 2023 Nov; 42(1):328. PubMed ID: 38031171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia and the Metastatic Niche.
    Chan CY; Yuen VW; Wong CC
    Adv Exp Med Biol; 2019; 1136():97-112. PubMed ID: 31201719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance.
    Bedeschi M; Marino N; Cavassi E; Piccinini F; Tesei A
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastases in Prostate Cancer.
    Manna F; Karkampouna S; Zoni E; De Menna M; Hensel J; Thalmann GN; Kruithof-de Julio M
    Cold Spring Harb Perspect Med; 2019 Mar; 9(3):. PubMed ID: 29661810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paget's "Seed and Soil" Theory of Cancer Metastasis: An Idea Whose Time has Come.
    Akhtar M; Haider A; Rashid S; Al-Nabet ADMH
    Adv Anat Pathol; 2019 Jan; 26(1):69-74. PubMed ID: 30339548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forces at play: exploring factors affecting the cancer metastasis.
    Riaz F; Zhang J; Pan F
    Front Immunol; 2024; 15():1274474. PubMed ID: 38361941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
    Futakuchi M; Fukamachi K; Suzui M
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.